Gastrointestinal Neoplasms
Oncology·MeSH: Gastrointestinal Neoplasms
3 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Phase 2(1)
| Drug | Company |
|---|---|
| Bezuclastinib | Cogent Biosciences, Inc. (COGT) |
Compare drugs
Frequently asked questions
How many drugs are in development for Gastrointestinal Neoplasms?
BioSniper tracks 3 drugs in development for Gastrointestinal Neoplasms across 2 companies.
How many clinical trials target Gastrointestinal Neoplasms?
There are 3 clinical trials targeting Gastrointestinal Neoplasms tracked by BioSniper.
Deep-dive into Gastrointestinal Neoplasms
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis